Charles River Laboratories International CRL
NYSE CRL
$304.27 +5.25 (+1.76%)
As of: Oct 14, 2026 · 1:28 PM EDT

Charles River Laboratories International (CRL) Long-Term Investments (2010 - 2026)

Updated

Charles River Laboratories International's Long-Term Investments was $206.47 million in Q2 2026, down 4.4% from $216.07 million a year earlier and down 1.6% from the prior quarter.

Analysis

Charles River Laboratories International (CRL) Long-Term Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Long-Term Investments at Charles River Laboratories International came in at $206.97 million, down 5.2% from FY2024.

  • Long-Term Investments has now declined for three consecutive years, with a five-year compound annual growth rate of -1.4% (FY2020 to FY2025).
  • In earlier years, Long-Term Investments was $218.35 million in FY2024 (-10.4%), $243.81 million in FY2023 (-21.8%), $311.6 million in FY2022 (+54.8%) and $201.35 million in FY2021 (-9.2%).
  • Quarterly Long-Term Investments has moved between $60.58 million (Q1 2022) and $311.6 million (Q4 2022) over five years.
  • Compared with a year earlier, Long-Term Investments has declined for 11 straight quarters, with an average decline of 10.0% over the last eight quarters.
  • The best year-over-year quarter for Long-Term Investments over five years was Q1 2023 (growth of 385.0%); the worst was Q2 2024 (a decline of 22.8%).
  • Per Business Quant data, CRL's Long-Term Investments in the three quarters before Q2 2026 was $209.72 million (Q1 2026), $206.97 million (Q4 2025) and $194.64 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Iqvia Holdings 43.55 Bn 35.26 Bn 1.44 Bn 390.00 Mn
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn -
3 Charles River Laboratories International 14.61 Bn 13.81 Bn 363.37 Mn 206.47 Mn
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn 107.23 Mn
5 Fortrea Holdings 2.05 Bn 1.43 Bn 139.20 Mn -
6 Ginkgo Bioworks Holdings 726.50 Mn -35.58 Mn 18.44 Mn 14.78 Mn
7 Evotec SE 504.32 Mn -1.11 Bn - 3.97 Mn
8 Champions Oncology 67.13 Mn 42.21 Mn 7.70 Mn -
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn -
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 27, 2026 206.47 Mn
Mar 28, 2026 209.72 Mn
Dec 27, 2025 206.97 Mn
Sep 27, 2025 194.64 Mn
Jun 28, 2025 216.07 Mn
Mar 29, 2025 214.03 Mn
Dec 28, 2024 218.35 Mn
Sep 28, 2024 235.99 Mn
Jun 29, 2024 231.86 Mn
Mar 30, 2024 243.54 Mn
Dec 30, 2023 243.81 Mn
Sep 30, 2023 301.85 Mn
Jul 1, 2023 300.28 Mn
Apr 1, 2023 293.79 Mn
Dec 31, 2022 311.60 Mn
Sep 24, 2022 158.58 Mn
Jun 25, 2022 151.20 Mn
Mar 26, 2022 60.58 Mn
Dec 25, 2021 201.35 Mn
Dec 26, 2020 221.80 Mn
API Access

Charles River Laboratories International Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CRL&period=max&api_key=YOUR_API_KEY